4/A

AMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Company: SAB Biotherapeutics, Inc.
Filed: November 15, 2023
Period of Report: November 10, 2023
Accession Number: 0001062993-23-020902

View Document ↗ View on SEC.gov ↗